Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;51(8):781-789.
doi: 10.1111/ceo.14292. Epub 2023 Sep 13.

Long term outcome and prognostic indicators in Posner Schlossman syndrome

Danica M Joseph  1 , Lyndell L Lim  2   3 , Priya D Samalia  2   3 , Jane M Wells  4   5 , Peter J McCluskey  1   6 , Eldho Paul  7   8 , Anthony J Hall  7   9
Affiliations

Long term outcome and prognostic indicators in Posner Schlossman syndrome

Danica M Joseph et al. Clin Exp Ophthalmol. 2023 Nov.

Abstract

Background: Posner Schlossman syndrome is a well-defined uveitis entity that is characterised by relapsing remitting unilateral anterior uveitis with markedly raised intraocular pressure. The aim of this study was to determine the risk factors for progression in patients with Posner Schlossman syndrome.

Methods: Ninety-eight patients were enrolled in a retrospective case series. Progression was defined as a composite endpoint of any of development of permanent glaucoma (in patients with no evidence of glaucomatous loss on presentation), corneal failure, or chronic inflammation. Relapse was defined as a resolving episode of inflammation not meeting the criteria for progression.

Results: Seventy seven percent of patients relapsed on average each 2.2 years. Forty percent of patients progressed. On univariate analysis, increased age at enrolment, immunocompromise at enrolment, the presence of glaucomatous optic neuropathy at enrolment, the performance of an anterior chamber tap and a positive anterior chamber tap were all associated with increased risk of progression. On multivariate analysis, age at enrolment, immunocompromise at enrolment, the performance of an anterior chamber tap, and the presence of glaucomatous optic neuropathy at enrolment were independently associated with increased risk of disease progression.

Conclusions: Posner Schlossman syndrome is not a benign uveitis entity and risk of both relapse and progression are high. Older patients, immunocompromised patients, patients with glaucomatous optic neuropathy at enrolment and those with a positive anterior chamber tap are all at increased risk of progression.

Keywords: cytomegalovirus; glaucoma; uveitis.

PubMed Disclaimer

References

REFERENCES

    1. Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthalmol. 1948;39(4):517-535. doi:10.1001/archopht.948.00900020525007
    1. Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65(2):184-190. doi:10.1007/s10384-020-00809-1
    1. Jap A, Sivakumar M, Chee SP. Is Posner Schlossman syndrome benign? Ophthalmology. 2001;108(5):913-918. doi:10.1016/s0161-6420(01)00551-6
    1. Su CC, Hu FR, Wang TH, et al. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol. 2014;158(5):1024-1031.e2. doi:10.1016/j.ajo.2014.08.007
    1. Kass MA, Becker B, Kolker AE. Glaucomatocyclitic crisis and primary open-angle glaucoma. Am J Ophthalmol. 1973;75(4):668-673. doi:10.1016/0002-9394(73)90818-0

LinkOut - more resources